News

ISN Journal editorial selections on dapagliflozin, Thailand’s CKD strategy, and misleading pseudocrescents in glomerulopathy 

Kidney International®   New insights from DAPA-CKD indicate that dapagliflozin modulates key pathways related to kidney outcomes  Dapagliflozin improves kidney outcomes in chronic kidney disease (CKD), but the mechanisms behind these benefits are not fully understood.   This DAPA-CKD proteomic analysis found that dapagliflozin modifies biological pathways linked to CKD progression, particularly those involving inflammation, fibrosis, and tissue remodeling.   The...

ISN global engagement in October: supporting kidney care education in France and Bosnia and Herzegovina  

This October, the ISN will contribute to nephrology events in France and Bosnia and Herzegovina.  11th Annual Congress of Société Francophone de Néphrologie Dialyse et Transplantation (SFNDT)  October 13-16, 2026 Paris, France  Join the ISN-ERA Joint Session on Wednesday, October 14, from 14:15-15:30 (Central European Summer Time).   ISN Emerging Leaders Program member Yannick Nlandu will moderate the session.     21st...

Explore content on novel treatments for kidney disease  

Wei Chen presenting at the ISN Frontiers meeting in Dalian, China  Selected content from the recent ISN Frontiers meeting in Dalian is now available at the ISN Academy.   Explore ISN Frontiers content  Discover ISN Frontiers industry content  Revisit key sessions and industry symposia on emerging treatments, artificial intelligence, rare kidney diseases, cardio-kidney-metabolic care, and more. Explore the Kidney International...

Build practical skills in managing AKI in the tropics with a new ISN Academy course 

How should clinicians recognize, assess, and manage acute kidney injury (AKI) linked to infections commonly encountered in tropical settings?  A new ISN Academy course, “Acute Kidney Injury in the Tropics,” offers a focused review of the pathophysiology, diagnosis, management, and prevention of infection-related AKI, with practical guidance relevant to both adult and pediatric care.  Explore the...

Gain global recognition through Fellow of the ISN status 

Your work has helped move kidney care forward. Could it be time for that contribution to receive international recognition?  Professional recognition is more than a title. It can signal to colleagues and patients that an igloball professional community has acknowledged your work, experience, and commitment to kidney care.  The Fellow of the International Society of Nephrology...

More accessible ISN membership in 2027: lower fees, same benefits 

Want to stay at the forefront of global kidney health, deepen your expertise, collaborate with peers worldwide, and access opportunities that can move your career forward?  In 2027, the ISN is making membership even more accessible to kidney health professionals around the world, while continuing to provide the benefits, resources and opportunities members value.  Explore the...

Elevating patient experience within clinical care: Rita Charon to present plenary session on narrative medicine at WCN’27 

Behind every diagnosis is a patient with their own experiences, priorities, and story. Narrative medicine asks clinicians to pay closer attention to these stories and how they can inform medical decision-making.   Rita Charon (USA), a professor of medicine, literary scholar, and co-founder of the field of narrative medicine, will present “Narrative Power for Patients and...

ISN members, put your expertise in service of global kidney health: Apply to an ISN committee or working group 

This is your opportunity to lead, share your expertise, and collaborate with colleagues from around the world.  Expressions of interest are now open for positions on ISN committees and working groups for terms starting at the World Congress of Nephrology 2027.  ISN committee and working group members guide and shape the execution of ISN’s strategic activities...

WKD 2027 campaign launches with new challenge and grant program 

World Kidney Day (WKD) launched its 2027 campaign, “Kidneys, heart, and metabolism: the core of your health,” on September 14. The campaign highlights the importance of caring for kidney, cardiovascular, and metabolic health as interconnected parts of overall health.    Get creative  This year, WKD invites everyone to take part in the new “Kidney Shape Challenge”: find, create, or capture something kidney-shaped in...

ISN Advocacy Newsletter – Bridging the Gaps – September 2026

Raising kidney health’s profile on the global agenda Dear Colleagues and Friends, Kidney health continues to gain ground on the global health agenda, and ISN activities at the 81st United Nations General Assembly gave us another important opportunity to build on that progress. During the event, the ISN helped lead the discussion on moving beyond single-disease approaches...

ISN Journal summaries on pegcetacoplan, AVF maturation failure, and primary hyperoxaluria type 1 

Kidney International®   Real-world outcomes of pegcetacoplan in primary membranoproliferative glomerulonephritis  Pegcetacoplan is being explored as a treatment for C3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis, but real-world evidence remains limited.   This observational study followed 25 pediatric and adult patients treated outside clinical trials, most of whom had not responded to conventional therapies.   Pegcetacoplan was associated with rapid...

Get ready for WCN’27: 3 ways to take action now 

Start shaping your World Congress of Nephrology 2027 (WCN’27) experience now, with opportunities to get involved before the congress takes place.  Share your research: Submit an abstract by October 28  Submit your research to WCN’27 for the chance to share it on a global stage and contribute to the scientific exchange that moves nephrology forward. Previous...

Patient voices shaping better kidney care: from addressing system barriers to patient advocacy 

  ​  ​   Manvir Victor (left) and Bill Wang  From navigating diagnosis and treatment to the practical and emotional challenges of everyday life, members of the ISN Patient Liaison Advisory Group shared what it means to live with kidney disease.   Challenging "systemic blindness" in kidney care  For Bill Wang in Hong Kong, one of the defining challenges...

ISN International Expert Forum explores complement therapeutics in clinical practice 

Speakers and delegates at the International Expert Forum: Complement Therapeutics in Clinical Practice in Kidney Disease in Singapore As complement therapeutics expand across kidney diseases, how should clinicians decide when to use them, how to monitor response, and when to change or stop treatment?  From September 16-18, 113 experts from 32 countries gathered in Singapore for...

Help build a clearer picture of international travel for organ transplantation 

You are invited to participate in an important anonymous online survey, “International travel for organ transplantation: surveying professionals’ experience,”* led by Dominique Martin and Georgina Irish from Deakin University and the Adelaide University, Australia.   The survey should take 5-15 minutes to complete and is available in 13 languages.  Complete the survey  Repeated every two years to track...

ISN leads the discussion on kidney health action and sustainable health systems for NCDs at UNGA81

Brussels, September 23, 2026 At the 81st session of the United Nations General Assembly (UNGA81), the International Society of Nephrology (ISN) continued to drive on how to turn the WHO kidney health resolution into action, working with partners across disease areas and linking kidney health to the broader agenda of stronger, more sustainable health systems...

ISN International Expert Forum report examines the evolving use of complement inhibitors in C3G and IgAN 

New complement-targeting treatments are changing the therapeutic landscape for C3 glomerulopathy (C3G), primary immune-complex membranoproliferative glomerulonephritis (IC-MPGN), and IgA nephropathy (IgAN), raising important questions about how to use them in clinical practice. To explore these questions, the ISN convened the 2025 ISN Expert Forum on Complement Therapeutics in C3G & IgAN.  Read the meeting report in Kidney International®  The...

ISN Journal editorial selections  

Kidney International®   Respiratory syncytial virus vaccination induces delayed but robust humoral and cellular immunity in patients receiving hemodialysis   Patients receiving hemodialysis are especially vulnerable to respiratory syncytial virus (RSV), but vaccine responses in this group are poorly understood.   In a small observational study, the RSV vaccine Arexvy produced robust antibody and cellular immune responses, although antibody levels rose more slowly than...

Outcomes from the ISN International Expert Forum on cardiovascular-kidney-metabolic care published in KI 

Cardiovascular disease, chronic kidney disease, diabetes, and obesity are closely interconnected, yet care is often delivered through separate clinical pathways. In October 2025, the ISN convened the ISN International Expert Forum, “Exploring the Nexus of Cardiovascular-Kidney-Metabolic (CKM) Health,” to examine how a more integrated CKM approach could improve prevention, treatment, and care delivery. The resulting meeting report has...

Share practical kidney care tools with primary care colleagues, now available in additional languages 

The ISN’s practical kidney care “cheat sheets” for primary care are now available in French and Spanish, alongside the original English version, making it easier to share clear, concise kidney care guidance with primary care colleagues in different geographies. Japanese, German, and Chinese translations will follow soon.  Explore the “cheat sheets” and share them with your primary care colleagues  Designed as quick-reference resources for primary...